Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis

Cited by (629)

Items 301–400 of 629

1. Current and emerging biologic therapies for allergic rhinitis and chronic rhinosinusitis
   Amelia Licari, Riccardo Castagnoli, Maria De Filippo, Thomas Foiadelli, Maria Angela Tosca, Gian Luigi Marseglia, Giorgio Ciprandi · 2020 · Expert Opinion on Biological Therapy
2. Monoclonal Antibodies and Airway Diseases
   Annina Lyly, Anu Laulajainen‐Hongisto, Philippe Gevaert, Paula Kauppi, Sanna Katriina Toppila-Salmi · 2020 · International Journal of Molecular Sciences
3. Systemic barrier dysfunction in type 2 inflammation diseases: perspective in the skin, airways, and gastrointestinal tract
   Juan Meng, Hao Xiao, Feng Xu, Xueke She, Chun‐Tao Liu, Giorgio Walter Canonica · 2025 · Immunologic Research
4. Is it severe asthma or asthma with severe comorbidities?
   Luisa Brussino, Paolo Solidoro, Giovanni Rolla · 2017 · Journal of Asthma and Allergy
5. Baicalin suppresses type 2 immunity through breaking off the interplay between mast cell and airway epithelial cell
   Kanako Yoshida, Tetsuji Takabayashi, Atsushi Kaneko, Mikina Takiyama, Masafumi Sakashita, Yoshimasa Imoto, Yukinori Kato, Norihiko Narita, Shigeharu Fujieda · 2020 · Journal of Ethnopharmacology
6. Diagnosis and Management of Rhinosinusitis: Highlights from the 2015 Practice Parameter
   Kathleen Dass, Anju Tripathi Peters · 2016 · Current Allergy and Asthma Reports
7. Allergic bronchopulmonary aspergillosis complicated by eosinophilic chronic rhinosinusitis successfully treated with mepolizumab
   Nobuhiro Matsumoto, Takafumi Shigekusa, Ayako Matsuo, Hironobu Tsubouchi, Shigehisa Yanagi, Masamitsu Nakazato · 2019 · Respirology Case Reports
8. Effect of monoclonal antibodies on olfactory dysfunction caused by chronic rhinosinusitis with nasal polyps: a systematic review and meta‐analysis
   Nikolaos Tsetsos, Konstantinos D. Markou, Iordanis Konstantinidis · 2020 · International Forum of Allergy & Rhinology
9. How to compare the efficacy of biologic agents in asthma
   Ravi K. Viswanathan, William W. Busse · 2020 · Annals of Allergy Asthma & Immunology
10. Biologics for atopic diseases: Indication, side effect management, and new developments
    Uta Jappe, Hendrik Beckert, Karl‐Christian Bergmann, Aşkın Gülşen, Ludger Klimek, Sandra Philipp, Julia Pickert, Michèle Myriam Rauber, Harald E. Renz, Christian Taube et al. · 2021 · Allergologie
11. Current State of Monoclonal Antibody Therapy for Allergic Diseases
    Yan Chen, Wei Wang, Huihui Yuan, Yan Li, Zhe Lv, Ye Cui, Jie Liu, Sun Ying · 2021 · Engineering
12. Chronic rhinosinusitis management beyond intranasal steroids and saline solution irrigations
    Newton Li, Anju Tripathi Peters · 2015 · Allergy and Asthma Proceedings
13. Impact of allergy on phenotypic and endotypic profiles of nasal polyposis
    G. Mortuaire, Isabelle M. Gengler, Maïté Balden, Moníque Capron, Guillaume Lefèvre · 2017 · European Annals of Otorhinolaryngology Head and Neck Diseases
14. Economic considerations on the usage of biologics in the allergy clinic
    Pauline Azzano, Élise Dufresne, Thomas G. Poder, Philippe Bégin · 2020 · Allergy
15. Serum IL-5, POSTN and IL-33 levels in chronic rhinosinusitis with nasal polyposis correlate with clinical severity
    Hanna Zielińska‐Bliźniewska, Milena Paprocka-Zjawiona, Anna Merecz-Sadowska, Radosław Zajdel, Katarzyna Maria Bliźniewska-Kowalska, Katarzyna Malinowska · 2022 · BMC Immunology
16. Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study
    Wytske Johanna Fokkens, Andrew Trigg, Stella E. Lee, Robert H. Chan, Zuzana Diamant, Claire L Hopkins, Peter Hugo Howarth, Valerie Joan Lund, Bhabita Mayer, Ana R. Sousa et al. · 2023 · Journal of Patient-Reported Outcomes
17. Cutaneous Manifestations of Reactions to Biologics
    Iris M. Otani, Amy S. Levin, Aleena Banerji · 2018 · Current Allergy and Asthma Reports
18. Group 2 innate lymphoid cells and eosinophilic chronic rhinosinusitis
    Ichiro Tojima, Takeshi Shimizu · 2018 · Current Opinion in Allergy and Clinical Immunology
19. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis
    Peter William Hellings, Cezmi A. Akdiş, Claus Bachert, Jean Bousquet, Pugin, B., Gwijde Flavius Jacobus Petrus Maria Adriaensen, Advani, R., Ioana Octavia Agache, Carlos Anjo, Rajesh Anmolsingh et al. · 2017 · Rhinology Journal
20. Use of biologics in chronic sinusitis with nasal polyps
    Chengshuo Wang, Luo Zhang · 2019 · Current Opinion in Allergy and Clinical Immunology
21. Clinical Significance of Cytoplasmic IgE-Positive Mast Cells in Eosinophilic Chronic Rhinosinusitis
    Yuka Gion, Mitsuhiro Okano, Takahisa Koyama, Tokie Oura, Asami Nishikori, Yorihisa Orita, Tomoyasu Tachibana, Hidenori Marunaka, Takuma Makino, Kazunori Nishizaki et al. · 2020 · International Journal of Molecular Sciences
22. Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: A randomized controlled clinical trial
    Caroline P.E. Price, Amina Guo, Whitney W. Stevens, Leslie P. Cousens, Thanh‐Huyen T. Vu, Lydia A. Suh, Kristin A. Erickson, David B. Conley, Leslie C. Grammer, Robert C. Kern et al. · 2022 · Clinical & Experimental Allergy
23. Perspectives in Therapy of Chronic Rhinosinusitis
    Jacek Brzost, Katarzyna Czerwaty, Karolina Dżaman, Nils Ludwig, Katarzyna Piszczatowska, Mirosław J. Szczepański · 2022 · Diagnostics
24. A Decade of Clinical Advances in Chronic Rhinosinusitis: 2012–2022
    Robert M. Naclerio, Joaquim Mullol, Whitney W. Stevens · 2023 · The Journal of Allergy and Clinical Immunology In Practice
25. Efficacy of different biologics for treating chronic rhinosinusitis with nasal polyps: a network meta-analysis
    Huikang Wang, Xinjun Xu, Zhaoyang Lu, Zhaoxue Zhai, Liting Shao, Xicheng Song, Yu Zhang · 2024 · European Archives of Oto-Rhino-Laryngology
26. Reslizumab in the management of poorly controlled asthma: the data so far
    Diego Jose Maselli, Maria Velez, Linda Joanne Rogers · 2016 · Journal of Asthma and Allergy
27. Histopathologic analysis in the diagnosis and management of chronic rhinosinusitis
    Aryan D. Shay, Bobby A. Tajudeen · 2018 · Current Opinion in Otolaryngology & Head & Neck Surgery
28. Asthma and Chronic Rhinosinusitis: Diagnosis and Medical Management
    Daljit Mann, Sukaina Hasnie, Kibwei A. McKinney · 2020 · Springer eBooks
29. Immune profile modulation of blood and mucosal eosinophils in nasal polyposis with concomitant asthma
    G. Mortuaire, Isabelle M. Gengler, Claire Vandenhende-Szymanski, Marie Delbeke, Solène Gatault, Dominique Chevalier, Lionel Prin, Moníque Capron · 2015 · Annals of Allergy Asthma & Immunology
30. Endoscopic grading systems for nasal polyps: are we comparing apples to oranges?
    Per Gisle Djupesland, Sietze Reitsma, Claire L Hopkins, Ahmad R. Sedaghat, Anju Tripathi Peters, Wytske Johanna Fokkens · 2022 · Rhinology Journal
31. Role and Function of Regulatory T Cell in Chronic Rhinosinusitis with Nasal Polyposis
    Chenyang Lei, Juan Jiang, Yanyan Zhang, Gaoyun Xiong · 2022 · Journal of Immunology Research
32. Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab: Real-World Use and Outcomes
    Isaac L. Schmale, Alexander Poulakis, Audrey M. Abend, Martha E. Luitje, Li‐Xing Man · 2023 · The Journal of Allergy and Clinical Immunology In Practice
33. Biological Modulators in Eosinophilic Diseases
    Panida Sriaroon, Mark C. Ballow · 2014 · Clinical Reviews in Allergy & Immunology
34. Upper airways in aspirin-exacerbated respiratory disease
    Jeong‐Hee Choi, Jihye Kim, Hae‐Sim Park · 2014 · Current Opinion in Allergy and Clinical Immunology
35. Biology of Eosinophils
    Hirohito Kita, Bruce Scott Bochner · 2014 · Elsevier eBooks
36. Endotypes of chronic rhinosinusitis with nasal polyps with and without NSAID – intolerance
    U.S. Steiner, S. Bischoff, Alan Valaperti, Kristian Ikenberg, J. Starzyk, S. Bucher, Lucas M. Bachmann, Michael Soyka · 2020 · Rhinology Journal
37. Aspirin‐exacerbated respiratory disease: Update on medical management
    Andrew A. White, Katharine M. Woessner, Ronald A. Simon · 2020 · World Journal of Otorhinolaryngology - Head and Neck Surgery
38. Contemporary Pharmacotherapy for Allergic Rhinitis and Chronic Rhinosinusitis
    Saied Ghadersohi, Bruce K. Tan · 2017 · Otolaryngologic Clinics of North America
39. An update on the management of aspirin-exacerbated respiratory disease
    Ji-Ho Lee, Chang‐Gyu Jung, Hae‐Sim Park · 2017 · Expert Review of Respiratory Medicine
40. Safety review of current systemic treatments for severe chronic rhinosinusitis with nasal polyps and future directions
    D Ranford, Claire L Hopkins · 2021 · Expert Opinion on Drug Safety
41. A novel inflammatory endotype diagnostic model based on cytokines in chronic rhinosinusitis with nasal polyps
    Meng‐Yu Chen, Zhaofeng Xu, Yiwei Fu, Nan Zhang, Tong Lu, Zhengqi Li, Jian Li, Claus Bachert, Weiping Wen, Yihui Wen · 2023 · World Allergy Organization Journal
42. Human intraepithelial mast cell differentiation and effector function are directed by TGF-β signaling
    Tahereh Mina Derakhshan, Eleanor Hollers, Alexander Perniss, Tessa Ryan, Alanna McGill, Jonathan Hacker, Regan W. Bergmark, Neil Bhattacharyya, Stella E. Lee, Alice Z. Maxfield et al. · 2025 · Journal of Clinical Investigation
43. Mepolizumab treatment for asthma
    Douglas S. Robinson · 2012 · Expert Opinion on Biological Therapy
44. A synthetic glycosaminoglycan reduces sinonasal inflammation in a murine model of chronic rhinosinusitis
    Jeremiah A. Alt, Won Yong Lee, Brock M. Davis, Justin R. Savage, Thomas P. Kennedy, Glenn D. Prestwich, Abigail Pulsipher · 2018 · PLoS ONE
45. Immunological profiling of key inflammatory drivers of nasal polyp formation and growth in chronic rhinosinusitis
    Timothy C. Biggs, Stephen M. Hayes, Philip G. Harries, R.N. Allan, Andrew F. Walls, Sylvia L. F. Pender, Rami J. Salib · 2019 · Rhinology Journal
46. The use of biologics in children with allergic rhinitis and chronic rhinosinusitis: Current updates
    Tan Shinee, Budi Sutikno, Baharudin Abdullah · 2019 · Pediatric Investigation
47. Chronic Rhinosinusitis
    Christopher Joseph Ocampo, Leslie C. Grammer · 2013 · The Journal of Allergy and Clinical Immunology In Practice
48. Favorable clinical efficacy of mepolizumab on the upper and lower airways in severe eosinophilic asthma: a 48-week pilot study
    M. Kurosawa, Katsutoshi OGAWA, P. Dorwal · 2019 · European Annals of Allergy and Clinical Immunology
49. A drug safety review of treating eosinophilic asthma with monoclonal antibodies
    Patrick Mitchell, Richard Leigh · 2019 · Expert Opinion on Drug Safety
50. Guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps (CRSwNP) in Brazil
    Wilma Terezinha Anselmo‐Lima, Edwin Tamashiro, Fabrizio Ricci Romano, Marcel M. Miyake, Renato Roithmann, Eduardo Macoto Kosugi, Márcio Nakanishi, Marco Aurélio Fornazieri, Thiago Freire Pinto Bezerra, João Ferreira de Mello et al. · 2021 · Brazilian Journal of Otorhinolaryngology
51. Effects of Mepolizumab in the treatment of type 2 CRSwNP: a real-life clinical study
    Pietro Orlando, Emanuele Vivarelli, Alberto Minzoni, Giuseppe Licci, Matteo Accinno, Barbara Brugnoli, Andrea Matucci, Alessandra Vultaggio, Giandomenico Maggiore · 2024 · European Archives of Oto-Rhino-Laryngology
52. Biologic therapy for atopic asthma and beyond
    Massimo Caruso, Emanuele Crisafulli, Raffaella Lizzio, Riccardo Polosa · 2013 · Current Opinion in Allergy and Clinical Immunology
53. Monoclonal Antibody Therapy in Sinonasal Disease
    Sergio E. Chiarella, Hendrik Sy, Anju Tripathi Peters · 2017 · American Journal of Rhinology and Allergy
54. Clinical and biological markers in disease and biologics to treat chronic rhinosinusitis
    Cuilian Guo, Chongshu Wang, Zheng Liu · 2021 · Current Opinion in Allergy and Clinical Immunology
55. Therapeutic Strategies to Prevent the Recurrence of Nasal Polyps after Surgical Treatment: An Update and In Vitro Study on Growth Inhibition of Fibroblasts
    Angela Rizzi, Luca Gammeri, Raffaele Cordiano, Mariagrazia Valentini, Michele Centrone, Sabino Marrone, Riccardo Inchingolo, Franziska Michaela Lohmeyer, Carlo Cavaliere, Francesco Ria et al. · 2023 · Journal of Clinical Medicine
56. Evidence-based Treatment of Chronic Rhinosinusitis with Nasal Polyps
    Rodney J. Schlosser, Zachary M. Soler · 2013 · American Journal of Rhinology and Allergy
57. Mepolizumab for eosinophilic severe asthma: recent studies
    Douglas S. Robinson, Harsha H. Kariyawasam · 2015 · Expert Opinion on Biological Therapy
58. Monoclonal Antibodies for the Treatment of Nasal Polyps
    Thomas J. Willson, Robert M. Naclerio, Stella E. Lee · 2017 · Immunology and Allergy Clinics of North America
59. Acquired Immunity in Chronic Rhinosinusitis
    Bruce K. Tan, Jin‐Young Min, Kathryn E. Hulse · 2017 · Current Allergy and Asthma Reports
60. Biologic Therapy and Asthma
    Ravi K. Viswanathan, William Busse · 2018 · Seminars in Respiratory and Critical Care Medicine
61. Effects of biological therapies on chronic rhinosinusitis in severe asthmatic patients
    Francesco Bandi, Stefania Gallo, Andrea Preti, Francesco Mozzanica, Dina Visca, Margherita Marelli, Enrico Maddalone, Cinzia Gambarini, Adriano Vaghi, Antonio Spanevello et al. · 2020 · Acta Otorhinolaryngologica Italica
62. Lessons learned from targeting eosinophils in human disease
    Fei Li Kuang, Bruce Scott Bochner · 2021 · Seminars in Immunopathology
63. Immunomodulators in chronic rhinosinusitis
    Philippe Lavigne, Stella E. Lee · 2018 · World Journal of Otorhinolaryngology - Head and Neck Surgery
64. Which Is the Best Biologic for Nasal Polyps: An Updated Network Meta‐Analysis
    Xi Tao XU, Jinting Lin, Minting Luo, Qingwu Wu · 2025 · Clinical and Translational Allergy
65. The management of paediatric rhinosinusitis
    Zohaib Siddiqui, Mauzammal Tahiri, Ahaan Gupta, Ronald Hang Kin Nam, Anastasia Rachmanidou · 2021 · International Journal of Pediatric Otorhinolaryngology
66. Critical review of diagnosis in rhinology and its therapeutical implications
    R. Jankowski, Valentin Favier, Nicolas Saroul, J.-B. Lecanu, D.T. Nguyen, Ludovic Le Taillandier de Gabory, Benjamin Vérillaud, C. Rumeau, P. Gallet, Émilie Béquignon et al. · 2023 · European Annals of Otorhinolaryngology Head and Neck Diseases
67. A real-world disproportionality analysis of mepolizumab based on the FDA adverse event reporting system
    Huqun Li, Chongshu Wang, Aiping Deng, Cuilian Guo · 2023 · Frontiers in Pharmacology
68. Monoclonal antibodies for the treatment of chronic rhinosinusitis with nasal polyposis: a systematic review
    2017 · Rhinology Journal
69. Medical management of chronic rhinosinusitis – a review of traditional and novel medical therapies
    Joseph S. Schwartz, Bobby A. Tajudeen, Noam A. Cohen · 2017 · Expert Opinion on Investigational Drugs
70. Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 update
    Wilma Terezinha Anselmo‐Lima, Fabrizio Ricci Romano, Edwin Tamashiro, Renato Roithmann, Vanessa Ramos Pires Dinarte, Otávio Bejzman Piltcher, Marcel M. Miyake, Marco Aurélio Fornazieri, Márcio Nakanishi, Thiago Freire Pinto Bezerra et al. · 2024 · Brazilian Journal of Otorhinolaryngology
71. Biologics in Chronic Rhinosinusitis
    Jacob T. Boyd, Ashoke R. Khanwalkar · 2024 · Immunology and Allergy Clinics of North America
72. Management of rhinosinusitis: an evidence based approach
    Andrew J. Para, Elisabeth Clayton, Anju Tripathi Peters · 2016 · Current Opinion in Allergy and Clinical Immunology
73. Activation state of circulating eosinophils in nasal polyposis
    Vincent Dupuch, Arlette Tridon, Sylvie Ughetto, Stéphane Walrand, Benjamin Bonnet, Claude Dubray, Aude Virlogeux, Marie‐Paule Vasson, Nicolas Saroul, T. Mom et al. · 2018 · International Forum of Allergy & Rhinology
74. Updates on current evidence for biologics in chronic rhinosinusitis
    Melina S. Nasta, Vasileios Chatzinakis, Christos Georgalas · 2019 · Current Opinion in Otolaryngology & Head & Neck Surgery
75. Targetable pathogenic mechanisms in nasal polyposis
    Alexander L. Schneider, Robert P. Schleimer, Bruce K. Tan · 2021 · International Forum of Allergy & Rhinology
76. EoE behaves as a unique Th2 disease: a narrative review
    Simon S. Rabinowitz, Liwei Yu, Patrick M. Geraghty · 2022 · Translational Gastroenterology and Hepatology
77. IL‐4/IL‐13 pathway in nasal type 2 inflammation: The central role and targeted therapy
    Zhiqiu Zhu, Chaoran Zhao, Ming Wang · 2024 · Eye & ENT Research
78. Efficacy of Biologics in NSAID-ERD: United Airways From the Nose to the Bronchi
    Kathleen M. Buchheit, Elke Vandewalle, Hester Beatrice Emilie Elzinga, Sietze Reitsma, Wytske Johanna Fokkens, P. Geveart · 2024 · The Journal of Allergy and Clinical Immunology In Practice
79. Nuclear Factor κB/MicroRNA-155 Upregulates the Expression Pattern of Cytokines in Regulating the Relapse of Chronic Sinusitis with Nasal Polyps and the Underlying Mechanism of Glucocorticoid
    Jianbin Du, Haijun Lv, Xin Dou, Zhongsheng Cao · 2020 · Medical Science Monitor
80. Effect of monoclonal antibody drug therapy on mucosal biomarkers in airway disease: A systematic review
    Sophie Walter, Jacqueline Ho, Raquel Alvarado, Janet Rimmer, Raewyn Gay Campbell, Larry Hilton Kalish, Raymond Sacks, Richard J. Harvey · 2020 · Clinical & Experimental Allergy
81. Stratégies de prise en charge de la polypose naso-sinusienne primitive de l’adulte
    Sophie Bartier, André Coste, Émilie Béquignon · 2021 · Revue des Maladies Respiratoires
82. Current and emerging biological therapies for Chronic rhinosinusitis with nasal polyps with type 2 inflammation
    Zeyi Jin, Bing Yan, Luo Zhang, Chengshuo Wang · 2023 · Expert Opinion on Investigational Drugs
83. Chronic rhinosinusitis
    Emmanuel P. Prokopakis, Ioannis Michael Vlastos, Harshita Pant, Berrylin J. Ferguson · 2012 · Current Opinion in Allergy and Clinical Immunology
84. Current complications and treatment of aspirin-exacerbated respiratory disease
    Kevin A. Cook, Donald D. Stevenson · 2016 · Expert Review of Respiratory Medicine
85. Pharmacological Management of Chronic Rhinosinusitis: Current and Evolving Treatments
    Daniel M. Beswick, Stacey Tutt Gray, Timothy L. Smith · 2017 · Drugs
86. Recent advances in biologic therapy of asthma and the role in therapy of chronic rhinosinusitis
    Rohit Dilip Divekar, Devyani Lal · 2018 · F1000Research
87. Heterogeneity of NSAID-Exacerbated Respiratory Disease
    Marek Leszek Kowalski · 2018 · Current Opinion in Pulmonary Medicine
88. Nasal Polyposis and Aspirin-Exacerbated Respiratory Disease
    Kathleen T. Luskin, Hiral Thakrar, Andrew A. White · 2020 · Immunology and Allergy Clinics of North America
89. Biotherapy and treatment of adult primary chronic rhinosinusitis with nasal polyps: Cellular and molecular bases
    Sophie Bartier, André Coste, Émilie Béquignon · 2020 · European Annals of Otorhinolaryngology Head and Neck Diseases
90. Practical clinical management strategies for the allergic patient with chronic rhinosinusitis
    Stella J. Lee, Summit Kundaria, Berrylin J. Ferguson · 2012 · Current Opinion in Otolaryngology & Head & Neck Surgery
91. Chinese Expert Consensus on the Use of Biologics in Patients with Chronic Rhinosinusitis (2022, Zhuhai)
    Haiyu Hong, Tengyu Chen, Qin-tai Yang, Yueqi Sun, Fenghong Chen, Hongfei Lou, Hongtian Wang, Ruili Yu, Yunfang An, Feng Liu et al. · 2023 · ORL
92. Tezepelumab improved chronic rhinosinusitis with nasal polyps in a Patient with aspirin exacerbated respiratory disease
    Yuga Yamashita, Kosuke Terada, Yuka Kodama, Ryo Nakadegawa, Hinako Masumitsu, Yuto Motobayashi, Reeko Osada, Hirokazu Takayasu, Nami Masumoto, Takeshi Kaneko et al. · 2024 · Respiratory Medicine Case Reports
93. Impact of reslizumab on the course of chronic rhinosinusitis in patients with eosinophilic asthma
    Н. В. Бойко, О.Е. Лодочкина, M.M. Kit, V.G. Kuleshova, N. G. Nedashkovskaya · 2021 · Russian Bulletin of Otorhinolaryngology
94. Targeting IL-5 in severe asthma: a DREAM come true?
    Simone Hashimoto, Elisabeth H. Bel · 2012 · The Lancet
95. The modern trends in the diagnostic search for and the treatment of chronic rhinosinusitis with nasal polyps
    Е. Л. Савлевич, V S Kozlov, Oksana Mikhaylovna Kurbacheva · 2018 · Russian Rhinology
96. Mepolizumab for eosinophilic chronic sinusitis with nasal polyposis: real-life experience
    F. Kassem, R. Cohen-Confino, Keren Meir‐Shafrir, Idit Lachover‐Roth, Anat Cohen‐Engler, Ben I. Nageris, Yossi Rosman · 2020 · Rhinology Journal
97. Phenotypes Determined by Cluster Analysis in Moderate to Severe Bronchial Asthma
    Vania Youroukova, Denitsa Dimitrova, Anna Valerieva, Spaska Lesichkova, Tsvetelina Veselinova Velikova, Ekaterina Ivanova‐Todorova, Kalina D. Tumangelova-Yuzeir · 2017 · Folia Medica
98. Chronic Rhinosinusitis and Aspirin-Exacerbated Respiratory Disease
    Neha M. Dunn, Rohit K. Katial · 2016 · Immunology and Allergy Clinics of North America
99. Transcription factors gene expression in chronic rhinosinusitis with and without nasal polyps
    Tanja Soklič Košak, Matija Rijavec, Mira Šilar, Ana Koren, Izidor Kern, Irena Hočevar Boltežar, Peter Korošec · 2019 · Radiology and Oncology
100. Chronic rhinosinusitis with nasal polyposis: the role of personalized and integrated medicine.
     Desiderio Passàli, Luisa Maria Bellussi, Valerio Damiani, MA Tosca, Gaetano Motta, Giorgio Ciprandi · 2020 · Acta bio-medica dell'Ateneo parmense/Acta biomedica